Curaleaf Holdings (CURLF) Accumulated Expenses (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Accumulated Expenses of $110.5 million for Q4 2025, up 8.13% year-over-year from $102.2 million in Q4 2024, and up 8.13% quarter-over-quarter from $102.2 million in Q4 2024.
Curaleaf Holdings (CURLF) Accumulated Expenses (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Accumulated Expenses history runs 7 years deep, the most recent figure standing at $110.5 million for Q4 2025.
- In Q4 2025, Accumulated Expenses rose 8.13% year-over-year to $110.5 million; the TTM figure through Dec 2025 stood at $110.5 million (up 8.13% YoY), while the FY2025 annual figure was $110.5 million, up 8.13% from the prior year.
- Accumulated Expenses for Q4 2025 stood at $110.5 million, up from $102.2 million in the prior quarter.
- The five-year high for Accumulated Expenses was $95.8 billion in Q1 2022, with the low at $54.4 million in Q1 2021.
- The 5-year median for Accumulated Expenses is $101.1 million (2023), against an average of $6.9 billion.
- The sharpest annual moves came in 2022 and 2024: Accumulated Expenses jumped 176163.61% in 2022, then rose 0.87% in 2024.
- Curaleaf Holdings' Accumulated Expenses stood at $87.0 million in 2021, then climbed by 9.63% to $95.3 million in 2022, then advanced by 6.26% to $101.3 million in 2023, then increased by 0.87% to $102.2 million in 2024, then rose by 8.13% to $110.5 million in 2025.
- Business Quant data shows CURLF's Accumulated Expenses at $110.5 million in Q4 2025, $102.2 million in Q4 2024, and $115.6 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 122.17 Mn |
| Dec 31, 2025 | 110.49 Mn |
| Dec 31, 2024 | 102.19 Mn |
| Sep 30, 2024 | 115.61 Mn |
| Jun 30, 2024 | 107.74 Mn |
| Dec 31, 2023 | 101.31 Mn |
| Sep 30, 2023 | 100.97 Mn |
| Jun 30, 2023 | 105.46 Mn |
| Sep 30, 2022 | 95.34 Mn |
| Jun 30, 2022 | 89.46 Mn |
| Mar 31, 2022 | 95.83 Bn |
| Dec 31, 2021 | 86.97 Mn |
| Sep 30, 2021 | 80.65 Mn |
| Jun 30, 2021 | 59.67 Mn |
| Mar 31, 2021 | 54.37 Mn |
| Dec 31, 2020 | 57.48 Mn |
| Sep 30, 2020 | 44.81 Mn |
| Dec 31, 2019 | 18.02 Mn |